Century Therapeutics, Inc. (IPSC)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 3.1200 |
| 開市 | 3.1300 |
| 買盤 | 0.0000 x 0 |
| 賣出價 | 0.0000 x 0 |
| 今日波幅 | 2.9800 - 3.3050 |
| 52 週波幅 | 1.2800 - 5.5100 |
| 成交量 | |
| 平均成交量 | 123,847 |
| 市值 | 252.857M |
| Beta 值 (5 年，每月) | 1.45 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.2200 |
| 業績公佈日 | 無 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 14.17 |
ZacksCentury Therapeutics, Inc. (IPSC) Reports Q1 Loss, Tops Revenue Estimates
Century Therapeutics (IPSC) delivered earnings and revenue surprises of 10% and 185%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksAmneal (AMRX) Stock Jumps 7.3%: Will It Continue to Soar?
Amneal (AMRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ZacksHow Much Upside is Left in Century Therapeutics, Inc. (IPSC)? Wall Street Analysts Think 193.4%
The average of price targets set by Wall Street analysts indicates a potential upside of 193.4% in Century Therapeutics, Inc. (IPSC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
